These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2105427

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X.
    NPN Med; 1985 Apr 02; 5(88):471-6. PubMed ID: 12315304
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.
    Cancer Epidemiol Biomarkers Prev; 1999 May 02; 8(5):413-9. PubMed ID: 10350436
    [Abstract] [Full Text] [Related]

  • 26. OCs and genital tract malignancies.
    Herbst AL.
    Dialogues Contracept; 1994 May 02; 4(3):5-7. PubMed ID: 12345575
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oral contraceptives and breast cancer: a case-control study with hospital and community controls.
    Schildkraut JM, Hulka BS, Wilkinson WE.
    Obstet Gynecol; 1990 Sep 02; 76(3 Pt 1):395-402. PubMed ID: 2381616
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Epidemiology of oral contraceptives and the risk of breast cancer.
    Webster L.
    J Reprod Med; 1986 Jun 02; 31(6 Suppl):540-5. PubMed ID: 3723486
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Oral contraceptives and breast cancer.
    Gay JW, Cardwell MS.
    Mo Med; 1990 Oct 02; 87(10):763-7. PubMed ID: 2259330
    [Abstract] [Full Text] [Related]

  • 37. Noncontraceptive health benefits and risks of steroidal contraception.
    Pasquale SA.
    Int J Fertil; 1989 Oct 02; 34 Suppl():85-7. PubMed ID: 2576266
    [Abstract] [Full Text] [Related]

  • 38. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 02; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 39. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia.
    Ravnihar B, Primic Zakelj M, Kosmelj K, Stare J.
    Neoplasma; 1988 Sep 02; 35(1):109-21. PubMed ID: 3352833
    [Abstract] [Full Text] [Related]

  • 40. Oral contraceptives and reproductive system cancer. Benefits and risks.
    Williams JK.
    J Reprod Med; 1991 Mar 02; 36(3 Suppl):247-52. PubMed ID: 2046078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.